Oruka Therapeutics CEO Lawrence Otto Klein reports sale of $2.39 million in common shares
ORKA•CEO and director Lawrence Otto Klein sold 25,000 Oruka Therapeutics shares on Nov. 2, 2026, at weighted-average prices ranging from $94.7718 to $98.4033 per share. He also exercised warrants to acquire 25,000 shares at $7.80 each.
1. Share sale and warrants
Klein sold 25,000 common shares on Nov. 2, 2026, at weighted-average prices ranging from $94.7718 to $98.4033 per share, and exercised employee warrants to acquire 25,000 common shares at $7.80 each. After the transactions, he directly owned 923,128 common shares and 1,503,513 employee warrants.
